Sign the Petition- HCV research funding conflicts of interests at NIH
Download - Printer Friendly Version
 

Contact:
NIH Directors
Institute and Center leaders

Mailing Addresses
for NIH Institutes and Centers

HCV Research

Track Funding

HCV Funded Studies:

HCV Research

HIV Research

Hepatitis B & Viral Hepatitis" Studies

Liver Disease Research

Unknown Category Research

Charts & Data

Treatments

Clinical Trials

Cirrhosis, HCC & Transplant Research

Mental Health

Harm Reduction

Snapshot NIH-TransPlan for HCV Funding

 

PRESS RELEASE:
Millions of  Dollars Redirected HepCop has publicly denounced the National Institutes of Health (NIH) for spending millions of dollars budgeted for Hepatitis C (HCV) on other research agendas.

National Center for Research Resources
NCRR

Total NCRR HCV Funding  
$2,275,861

Description Project Number Name Cost Project Title
Clinical Trial Liver Disease Research 5M01RR001032-33 AFDHAL, NEZAM $4,925 CLINICAL TRIAL: PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER
  2M01RR000046-48 HEATON, ROBERT $20,125 CLINICAL TRIAL: SILYMARIN (LEGALON?) IN NON-CIRRHOTIC SUBJECTS WITH CHRONIC HEP
Clinical Trial
HCV Research		 5M01RR000082-46 GREENBERG, HARRY $37,396 CLINICAL TRIAL: PEGYLATED INTERFERON RIBAVIRIN FOR CHILDREN WITH HCV PEDS-C
  5M01RR000827-33 MORGAN, TIMOTHY $66,677 CLINICAL TRIAL: HALT-C
  2M01RR001066-31 DOUDNA, JENNIFER $4,209 CLINICAL TRIAL: THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS
  5M01RR006192-15 BONKOVSKY, HERBERT $4,635 CLINICAL TRIAL: HALT-C TRIAL
  5M01RR008084-15 BALISTRERI, WILLIAM $5,201 CLINICAL TRIAL: PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV
  5M01RR000065-46 ROSEN, HUGO $213,512 CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
Harm Reduction HCV Research 5M01RR000827-33 HAHN, JUDITH $424,754 EFFECTS OF METHAMPHETAMINE & HCV
HBV/Viral Hep Research 5P51RR000165-48 GRETCH, DAVID $35,600 IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS
HCV Based Research 2M01RR000046-48 WILLIAMS, JEFFREY $76 IMPACT OF HEPATIC STEATOSIS ON HEPATITIS C
  2M01RR000043-48 LIOTTA, DENNIS $2,405 HCV RNA TESTING IN HALT-C SUSTAINED VIROLOGIC RESPONDERS
  5K23RR022206-03 RICE, CHARLES $153,792 HCV Kinetics and Determinants of Relapse
  5P51RR013986-10 LAUER, GEORG $1,015 HCV CENTER STUDIES ON INFECTIOUS HCV
  5M01RR012248-12 HUSSAIN, HERO $507 HEPC
  5M01RR000065-46 ROSEN, HUGO $20,100 QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
  5P51RR013986-10 MURTHY, KRISHNA $14,972 HCV NUCLEIC ACID VACCINE STUDIES IN CHIMPANZEES
  5P51RR013986-10 MURTHY, KRISHNA $1,649 RESTORING HCV-SPECIFIC T CELL FUNCTIONS IN CHRONIC HEPATITIS C
  5P51RR013986-10 MURTHY, KRISHNA $3,743 IMMUNOGENETHERAPY OF CHRONIC HCV CARRIER CHIMPANZEES
  5P51RR013986-10 MURTHY, KRISHNA $14,972 DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
  5P51RR013986-10 TAI, ANDREW $3,933 HCV REPLICATION AND IMMUNITY
  5P51RR013986-10 LAUER, GEORG $1,967 GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION
  5P51RR013986-10 MURTHY, KRISHNA $3,870 DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE
  5P51RR000165-48 GRETCH, DAVID $35,600 UNDERSTANDING MECHANISMS OF HCV PERSISTENCE
  5P51RR000165-48 GRETCH, DAVID $35,600 MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
  5P51RR000165-48 GRETCH, DAVID $35,600 HEPATITIS C VIRUS: DEFINING HOST DETERMINANTS OF INFECTION OUTCOME
  5P51RR013986-10 TAI, ANDREW $952 INTERFERON GAMMA AND CONTROL OF HCV REPLICATION
  5M01RR000051-47 LAU, DARYL $2,254 QUANTITATIVE LIVER FUNCTION IN EARLY FIBROSIS STAGE HCV INFECTION
  5P41RR000862-35 REDDY, RAJENDER $1,102 INVESTIGATIONS OF THE FUNCTION OF NS4B OF HCV
  5P41RR000862-35 REDDY, RAJENDER $1,102 NS5A PHOSPHORYLATION
  5P41RR000862-35 REDDY, RAJENDER $1,102 STUDY OF HCV RNA-PROTEIN INTERACTIONS
  5P41RR002250-23 RAISON, CHARLES $16,231 NS3 HELICASE
  5P41RR004050-20 BUCK, MARTINA $1,951 INFECTION AND REPLICATION OF NATURALLY OCCURRING HEPATITIS C VIRUS
  5P41RR011823-13 WEINMAN, STEVEN $819 IDENTIFICATION OF THE HEPATITIS C VIRUS (HCV) PROTEOME
  5M01RR000051-47 RITOLA, KIMBERLY $198 IMMUNE RESPONSES IN ACUTE HEPATITIS C INFECTION
  5P41RR002250-23 HOWELL, CHARLES $16,231 HEPATITIS C VIRUS
  5P41RR011823-13 RUSSELL, MARCIA $819 IDENTIFICATION OF NOVEL HOST FACTORS INTERACTING WITH NS5A PROTEIN OF HCV
  5U54RR019507-06 MAYOR, ANGEL $184,889 HCV RISK REDUCTION INTERVENTION AS SECONDARY CO-MORBIDITY PREVNT
  5P20RR016460-07 MATLOCK, DENNIS $30,939 UNWINDING&TRANSLOCATION OF DNA BY NS3 HELICASE FROM HEPATITIS C
  5M01RR000073-45 SCHACKMAN, BRUCE $28,483 SERUM MARKERS OF FIBROSIS IN CHRONIC HEPATITIS C
HIV/HCV Mental Health Research 5M01RR000071-45 RANGSIN, RAM $138,559 HIV/HCV: NEUROPSYCHIATRIC AND NEUROPHYSIOLOGIC FEATURES
HIV/HCV Research 2P41RR018522-06 KHAKOO, SALIM $52,949 HCV INFECTION AND HCV/HIV CO-INFECTION IN LIVER TISSUE
  5M01RR006192-15 BONA, ROBERT $1,842 HIV ON HEPATITIS C
  5M01RR000065-46 SCHUPPAN, DETLEF $354,208 HCV-HIV COINFECTION: IMPACT OF IMMUNE DYSFUNCTION
Interferon/Antivial Treatment HCV Research 5M01RR000073-45 SCHACKMAN, BRUCE $667 A PILOT STUDY TO CHARACTERIZE INTERFERON-INDUCED GENE EXPRESSION IN LIVER CELLS
  5P51RR013986-10 LAUER, GEORG $9,453 HCV ANTIVIRAL TESTING IN CHIMPANZEES
  5M01RR001346-27 SCHWARZ, KATHLEEN $289 REDUCING DEPRESSIVE SYMPTOMS DURING HCV THERAPY: A RANDOMIZED STUDY
  5P51RR013986-10 LAUER, GEORG $22,141 HCV ANTIVIRAL TESTING IN CHIMPANZEES
  5P51RR013986-10 LAUER, GEORG $381 HCV ANTIVIRAL TESTING IN CHIMPANZEES
  5P51RR013986-10 LAUER, GEORG $2,411 EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES
  5M01RR000051-47 FAN, XIAOFENG $17,798 HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
  5M01RR000750-36 MOLLESTON, JEAN $2,544 PEGINTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV
  5M01RR020359-04 MOHAN, PARVATHI $61,609 PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV
Interferon/Antivial Treatment HIV/HCV Research 2M01RR000046-48 WAGNER, GLENN $7,283 LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
  5M01RR000865-35 MOE, ARDIS $31,623 SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV
  5M01RR000051-47 CAMPBELL, THOMAS $14,142 SUPPRESSIVE LONG-TERM ANTIVIRAL MGMT OF HCV & HIV-1 COINFECTED SUBJECTS (SLAM-C)
  5M01RR000750-36 KALAMS, SPYROS $6,133 SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV
Liver Disease Research 5P51RR013986-10 LAUER, GEORG $1,713 CREATION OF IMMORTALIZED CHIMP AND BABOON HEPATOCYTE CELL LINES
  5P20RR017675-07 HAWKE, ROY $70,426 THE REDOX-MEDIATED REGULATION OF IRON-RESPONSIVE GENE EXPRESSION IN LIVER
Liver Transplant HCV 5M01RR000051-47 STRATHDEE, STEFFANIE $435 PHASE II TRIAL ASSESS SFTY OF IMNOSPRSN W/DRAWAL IN LIVER TRNSPLNT RECIP W/HEP C
  5M01RR000051-47 EXLEY, MARK $949 A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
Other Treatment Research 5P41RR001209-29 BUSSIERE, DIRKSEN $184 STRUCTURAL STUDIES ON KEY DRUG TARGETS: HUMAN KINASES AND NTP-BINDING PROTEINS
  5M01RR001032-33 LAW, MANSUN $5,699 RACIAL DIFFERENCES IN IFN TRANSCRIPTIONAL RESPONSE
Unknown/Non-Specific Research 5P41RR000862-35 REDDY, RAJENDER $2,218 INVESTIGATING THE FUNCTION OF NS4B OF BVDV
  5P51RR000165-48 GRETCH, DAVID $35,600 ROLE OF NONSTRUCTURAL PROTEINS IN PESTIVIRUS ASSEMBLY
  5P51RR013986-10 LAUER, GEORG $698 TLR LIGANDS IN GBV-B

Total NCRR NIH Funding  $2,275,861

 
 

Source: National Institutes of Health Research Portfolio Online Reporting Tool (RePORT) Reports,
Data and Analyses of NIH Research Activities
Retrieved on March 18, 2009
http://report.nih.gov/rcdc/categories/ProjectSearch.aspx?FY=2008&DCat=Hepatitis+-+C

Permission is granted to use all information from this website in pursuit of ending NIH's "Trans-Plan" discriminatory practices against HCV research funding allocations. Please Credit: HCVets.com Educational Website & Support Forums for Military Related HCV Exposures.

Contact HepCop   
Email: Staff